Researchers sought to determine if presence of comorbidities influences the underrepresentation of African American patients with acute myeloid leukemia in clinical trials.
No difference in event-free survival (EFS) was observed in children and adolescents with newly diagnosed Hodgkin lymphoma (HL) according to race/ethnicity; however, postrelapse mortality was found to be higher in nonwhite groups. The findings from this pooled, secondary analysis of data from phase 3 clinical trials of dose-dense, response-adapted therapy were published in the Journal…
Agreement between patient- and physician-reported adverse effects during phase 1 clinical trials varies from poor to fair.
Researchers identify trends in use of complementary medicine among patients with breast, colorectal, or lung cancer while participating in phase 3 clinical trials.
Researchers demonstrated the significance of access to supportive and posttrial care as it relates to cancer survival among clinical trial participants.